Ritratto di stefano.garofalo@uniroma1.it
Insegnamento Codice Anno Corso - Frequentare Bacheca
FISIOLOGIA GENERALE 1008197 2023/2024
ANATOMIA - ISTOLOGIA - FISIOLOGIA 10606039 2023/2024
FISIOLOGIA GENERALE 10611093 2023/2024
FISIOLOGIA GENERALE 1008197 2022/2023

online, previo appuntamento. link meet
https://meet.google.com/mic-bqey-pcu

EMPLOYMENTS

2021 -

2019-2021

2018

2017

2017

2016

Current position: Researcher (RTD A) at Sapienza University of Rome, since 23 Dicember 2021

Post-doctoral researcher - AIRC Fellowship (Associazione Italinana Ricerca sul Cancro) Dep. Molecular Medicine, Sapienza University, Rome, Italy
Post-Doctoral researcher Pasteur Insitute Italy, Cenci Bolognetti foundation, Rome, Italy
Post-Doctoral researcher IRCCS Neuromed, Via Atinense 18, 86077 Pozzilli, IS, Italy.
Internship in Neurophysiology Dep. of Neurobiology, Lab. Prof. Tarja Malm, University of Eastern Finland, Kuopio.
Post-Doctoral researcher (assegnista) Dep. Physiology and Pharmacology, Sapienza University, Rome, Italy.

ACADEMIC ROLE
Academic year 2021/2022 Sapienza University of Rome, Faculty of Medicine and Psychology: teaching activities for the module of Physiology - Degree course in Chimica e tecnologia del Farmaco BIO / 09.

Academic year 2020/2021 Sapienza University of Rome, Faculty of Medicine and Psychology: supplementary teaching activities for the module of Physiology - Degree course in Applied Pharmaceutical Sciences BIO / 09.

Academic year 2019/2020 and 2020/2021 Sapienza University of Rome, Faculty of Medicine and Psychology: supplementary teaching activities for the module of Advanced Morphofunctional Sciences and Techniques II - Degree course in Medical Biotechnology BIO / 09.

MEMBERSHIPS OF SCIENTIFIC SOCIETIES
2021-present Member, Italian Society of Physiology SIF
2017-present Member, Italian Society of Neuroimmunology AINI

EDUCATION AND ACADEMIC DEGREES

2012-2015

1992-1993

PhD Student in Neurophysiology Dep. Physiology and Pharmacology, Sapienza University, Rome, Italy. Tutor Prof. Cristina Limatola.

Master Degree in Neurobiology final mark: 110/110 cum laude. Dep. Cellular and Development Biology, Sapienza University, Rome, Italy.

Research interests: mechanisms of cellular communication in the central nervous system; role of glial cells in brain tumors; immune cell and glia interaction in physiological and pathological conditions; neuroinflammation in neurodegenerative diseases; role of glial cells in sleep.

ACHIEVEMENTS AND AWARD

Awards Young Research Awards 2020 for best published research in Department of Physiology and Pharmacology, University of Rome, Sapienza (2000 euros).
Young Research Awards 2017 for best published research in Department of Physiology and Pharmacology, University of Rome, Sapienza (2000 euros).
Winner of Grant for course EFIS-EJI Ruggero Ceppellini Advance school in immunology 2017.
Winner of Grant for AINIESNI2017 XXVI AINI Congress and ESNI 16th course 2017.
Young Research Awards 2015 for best published research in Department of Physiology and Pharmacology, University of Rome, Sapienza (2000 euros).

Editorial activity I refer to the following magazines: PeerJ (Life, Bio & Health Sciences); Brain, Behaviour and Immunity (BBI); Brain Research; Clinical immunology; Frontiers in cellular Neurosc.; Cellular and Molecular Immunology (CMI).

Guest Editor: Frontiers in Cellular Neuroscience in 2020
Frontiers in Cell and Development Biology in 2022

Majior invited presentations Speaker Invitation:
EpiEpinet Animal models of brain tumors, May 2022, Lisbon, Portugal
Cancer-2021 at the upcoming 8th International Meet on Cancer & Radiology, October 25-27, 2021 in Prague, Czech Republic
Role of microglia in brain tumors. XIX National Congress SINS, Sept 2021, Brescia, Italy.
Natural Killer cells modulate motor neuron-immune cell cross talk in models of ALS. 40° SIF (Società Italiana di Farmacologia) congress, March 2021, digital edition.
Environmental stimuli instruct innate immune system to fight brain tumors. CRiN Neuroscience Seminar, Sapienza University of Rome, March 2019, Rome, Italy.
Environmental stimuli shape microglial plasticity in glioma More than neuron Congress, Dec 2018, Turin, Italy
Role of NK cells in ALS. ARISLA (Fondazione Italiana per la Ricerca sulla Sclerosi Laterale Amiotrofica) Congress, Sept 2018, Genova, Italy
Environmental stimuli shape microglial plasticity in glioma. Microglia EMBO Congress, Mar 2018, Heiselberg, Germany.
Fluoxetine counteracts the opposite effects of stress and enrichment on the inflammatory response and microglial status. XVII National Congress SINS, Sept 2017, Ischia, Italy.

Grants Personal Funding:

ARISLA Pilot Grant 2019 (Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica) (57K euros).
AIRC (Associazione Italinana Ricerca sul Cancro) Fellowship David Raffaelli 2019-2021 (75K euros).
Avvio alla Ricerca 2016, Sapienza University of Rome (4000 euros).

Partecipation at the following research projects:
2020-2023 Research project: Reactivation of antitumor immune responses in gliomas using nanotechnology based targeted delivery. EUROPEAN INNOVATIVE RESEARCH & TECHNOLOGICAL DEVELOPMENT PROJECTS IN NANOMEDICINE 919.460 euros
2020-2024 Research project: Effect of microbiota modulation on tumor microenvironment in glioma. Associazione Italiana per la Ricerca sul Cancro (AIRC) 916.776 euros
2015-2019 Research project: New strategies to fight against glioma: in vivo studies to reprogram tumor-infiltrating microglia/macrophages Associazione Italiana per la Ricerca sul Cancro (AIRC) 916.776 euros
2016-2017 MicRobE-indUced immune modulation of glioma: effect of eNvIrONment MICROBES & BRAIN PROJECTS 2016: SEEDS FOR INNOVATION 200.000 euros
2018-2020 Targeting potassium channels to reprogram glioblastoma microenvironment: in vitro and in vivo studies. Bando Ricerca Finalizzata RF-2018-12366215 248.100 euros

2018-2020 PRIN: PROGETTI DI RICERCA DI RILEVANTE INTERESSE NAZIONALE Bando 2017 Prot. 20178L7WRS 905.365,88

Patents 1) Trattamento del tumore cerebrale" Deposit date; 22/12/2015; deposit number: 102015000086815 (UB2015A009141)

2) UTILIZZO DEL NATALIZUMAB PER LA CURA DELLE FORME FAMILIARI DI SCLEROSI LATERALE AMIOTROFICA DEPOSIT 08/03/2922